Kevin Kai Chih Chang, MD
Internal Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: 059546 · Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chang’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A152565 · Current
Licensed to practise in California · since 2017 · expires 2027-11-30 · New York University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$56,826
Medicare paid this office $56,826 for 524 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 187 | $16,465 | $58 |
| Short return visit (20+ min) | 144 | $7,999 | $50 |
| Return visit (30+ min) | 81 | $7,530 | $64 |
| Short return visit (20+ min) | 103 | $6,565 | $58 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 112 | $6,158 | $55 |
See all 8 services
| Return visit (30+ min) | 187 | $16,465 | $58 |
| Short return visit (20+ min) | 144 | $7,999 | $50 |
| Return visit (30+ min) | 81 | $7,530 | $64 |
| Short return visit (20+ min) | 103 | $6,565 | $58 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 112 | $6,158 | $55 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 130 | $2,316 | $15 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 23 | $1,348 | $59 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 57 | $1,094 | $15 |
Who their Medicare patients are
524 Original Medicare patients in 2024. Average age 74 · Under 65 10% · 85 and older 12% · Women 52% · Also on Medicaid 24% · Health risk score 1.33. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 59% · Diabetes 26% · Coronary heart disease 22% · Chronic kidney disease 20% · Cancer 18% · Heart failure 16% · Depression 16% · Atrial fibrillation 13% · COPD 9% · Stroke 8% · Dementia 7%.
The office billed $374,371, Medicare allowed $84,311 and paid $56,826; for 1,136 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 524 | 1,136 | 74 | 1.33 | $374,371 | $56,826 |
| 2023 | 510 | 954 | 73 | 1.66 | $334,163 | $58,279 |
| 2022 | 510 | 1,080 | 72 | 1.81 | $384,203 | $80,773 |
| 2021 | 333 | 693 | 71 | 1.45 | $239,156 | $42,310 |
| 2020 | 338 | 651 | 70 | 1.45 | $170,362 | $36,492 |
| 2019 | 113 | 146 | 72 | 1.53 | $14,241 | $10,408 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Return visit (30+ min) | 207 | $19,273 | $57 |
| Short return visit (20+ min) | 218 | $12,085 | $51 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 128 | $8,779 | $69 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $6,033 | $70 |
| Long return visit (40+ min) | 36 | $2,964 | $72 |
| Hospital discharge day management, 30 minutes or less | 25 | $1,758 | $70 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,752 | $117 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,393 | $107 |
2022: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 81 | $12,606 | $93 |
| Return visit (30+ min) | 129 | $12,133 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 82 | $10,259 | $65 |
| Short return visit (20+ min) | 165 | $10,237 | $50 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $8,013 | $182 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 90 | $6,273 | $70 |
| Long return visit (40+ min) | 40 | $3,944 | $77 |
| New patient visit (45+ min) | 24 | $3,342 | $139 |
| Hospital discharge day management, 30 minutes or less | 45 | $2,982 | $65 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 15 | $1,667 | $111 |
| New patient visit (30+ min) | 14 | $1,198 | $86 |
| Telephone medical discussion with physician, 11-20 minutes | 17 | $1,026 | $54 |
| Hospital observation care on day of discharge | 11 | $785 | $71 |
2021: 7 services
| Return visit (30+ min) | 185 | $17,914 | $62 |
| Short return visit (20+ min) | 141 | $8,956 | $49 |
| Long return visit (40+ min) | 51 | $6,055 | $85 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 62 | $3,404 | $55 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $1,745 | $73 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 12 | $1,015 | $85 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $727 | $48 |
2020: 8 services
| Return visit (30+ min) | 188 | $16,418 | $62 |
| Short return visit (20+ min) | 127 | $7,663 | $44 |
| Telephone medical discussion with physician, 21-30 minutes | 30 | $2,918 | $71 |
| Telephone medical discussion with physician, 11-20 minutes | 44 | $2,549 | $46 |
| Long return visit (40+ min) | 15 | $2,289 | $104 |
| Return visit (30+ min) | 20 | $1,542 | $73 |
| Short return visit (20+ min) | 23 | $1,049 | $44 |
| Telephone medical discussion with physician, 5-10 minutes | 16 | $399 | $23 |
2019: 2 services
| Return visit (30+ min) | 83 | $7,496 | $71 |
| Short return visit (20+ min) | 21 | $961 | $46 |
Medicaid work
$5,190 in 2024
Medicaid paid $5,190 for 309 billed services this clinician did in 2024, up to 29 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 212 | $4,112 |
| Short return visit (20+ min) | 65 | $990 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 32 | $88 |
| 2024 | 309 | 3 | 29 | $5,190 |
| 2023 | 447 | 3 | 32 | $5,992 |
| 2022 | 405 | 5 | 22 | $8,477 |
| 2021 | 259 | 2 | 24 | $3,437 |
| 2020 | 224 | 2 | 24 | $3,198 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 282 | $3,958 |
| Short return visit (20+ min) | 141 | $1,400 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 24 | $634 |
2022
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 108 | $2,804 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 82 | $2,392 |
| Return visit (30+ min) | 68 | $1,436 |
| Short return visit (20+ min) | 133 | $1,273 |
| 1ST HOSP IP/OBS HIGH 75 | 14 | $571 |
2021
| Return visit (30+ min) | 155 | $2,361 |
| Short return visit (20+ min) | 104 | $1,075 |
2020
| Return visit (30+ min) | 141 | $2,382 |
| Short return visit (20+ min) | 83 | $816 |
Drugs they prescribed that Part D paid
$617,271
Pharmacies billed $617,271 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (86 of 3,866) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
3,290 generic and 563 brand-name prescriptions · $617,271 in drug cost · 138 antibiotic prescriptions to 102 people · 14 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 64 | $103,524 | $1,618 |
| Mounjaro | 43 | $60,129 | $1,398 |
| Eliquis | 49 | $59,100 | $1,206 |
| Jardiance | 29 | $37,116 | $1,280 |
| Zenpep | 14 | $35,996 | $2,571 |
See all 87 drugs
| Ozempic | 64 | $103,524 | $1,618 |
| Mounjaro | 43 | $60,129 | $1,398 |
| Eliquis | 49 | $59,100 | $1,206 |
| Jardiance | 29 | $37,116 | $1,280 |
| Zenpep | 14 | $35,996 | $2,571 |
| Trulicity | 24 | $35,440 | $1,477 |
| Xarelto | 13 | $21,048 | $1,619 |
| Januvia | 13 | $17,635 | $1,357 |
| Vemlidy | 12 | $15,795 | $1,316 |
| Myrbetriq | 11 | $15,275 | $1,389 |
| Farxiga | 13 | $10,841 | $834 |
| Atrovent Hfa | 11 | $4,565 | $415 |
| Atorvastatin | 297 | $3,578 | $12 |
| Rosuvastatin | 124 | $3,366 | $27 |
| Tamsulosin | 123 | $2,944 | $24 |
| Paxlovid | 24 | $2,873 | $120 |
| Pregabalin | 17 | $2,228 | $131 |
| Duloxetine | 32 | $2,100 | $66 |
| Losartan | 204 | $1,921 | $9 |
| Albuterol Sulfate Hfa | 64 | $1,535 | $24 |
| Omeprazole | 75 | $1,288 | $17 |
| Hydrocodone-Acetaminophen | 41 | $1,222 | $30 |
| Metformin | 110 | $1,201 | $11 |
| Celecoxib | 11 | $1,154 | $105 |
| Wixela Inhub | 12 | $1,148 | $96 |
| Ezetimibe | 28 | $1,143 | $41 |
| Amlodipine Besylate | 164 | $1,009 | $6 |
| Levothyroxine | 95 | $933 | $10 |
| Gabapentin | 42 | $903 | $22 |
| Metoprolol | 67 | $898 | $13 |
| Ketoconazole | 38 | $822 | $22 |
| Losartan-Hydrochlorothiazide | 36 | $725 | $20 |
| Valsartan | 23 | $714 | $31 |
| Potassium Citrate Er | 12 | $630 | $52 |
| Fenofibrate | 15 | $624 | $42 |
| Pantoprazole | 63 | $587 | $9 |
| Lisinopril | 69 | $570 | $8 |
| Zolpidem | 22 | $539 | $24 |
| Nifedipine Er | 17 | $455 | $27 |
| Fluticasone Propionate | 36 | $451 | $13 |
| Clopidogrel | 14 | $382 | $27 |
| Ondansetron Odt | 20 | $351 | $18 |
| Trazodone | 55 | $347 | $6 |
| Propranolol Hcl Er | 12 | $346 | $29 |
| Oxycodone | 24 | $341 | $14 |
| Lovastatin | 16 | $337 | $21 |
| Triamcinolone Acetonide | 37 | $313 | $8 |
| Montelukast | 28 | $310 | $11 |
| Finasteride | 23 | $304 | $13 |
| Venlafaxine Hcl Er | 20 | $275 | $14 |
| Valacyclovir | 22 | $266 | $12 |
| Ciclopirox | 12 | $265 | $22 |
| Hydroxyzine | 21 | $262 | $12 |
| Carvedilol | 30 | $250 | $8 |
| Alendronate | 35 | $238 | $7 |
| Cyclobenzaprine | 25 | $237 | $9 |
| Pravastatin | 15 | $230 | $15 |
| Amoxicillin-Clavulanate Potass | 31 | $203 | $7 |
| Mirtazapine | 11 | $201 | $18 |
| Chlorthalidone | 12 | $187 | $16 |
| Baclofen | 13 | $186 | $14 |
| Triamterene-Hydrochlorothiazid | 18 | $180 | $10 |
| Allopurinol | 26 | $179 | $7 |
| Metoprolol | 34 | $177 | $5 |
| Sertraline | 21 | $176 | $8 |
| Metformin Hcl Er | 31 | $165 | $5 |
| Simvastatin | 52 | $164 | $3 |
| Zolpidem Tartrate Er | 11 | $139 | $13 |
| Furosemide | 24 | $132 | $5 |
| Lorazepam | 15 | $130 | $9 |
| Atenolol | 19 | $119 | $6 |
| Terazosin | 17 | $111 | $7 |
| Citalopram Hbr | 11 | $102 | $9 |
| Azithromycin | 32 | $98 | $3 |
| Hydrochlorothiazide | 42 | $84 | $2 |
| Ciprofloxacin | 16 | $84 | $5 |
| Chlorhexidine Gluconate | 16 | $80 | $5 |
| Ibuprofen | 16 | $80 | $5 |
| Famotidine | 13 | $78 | $6 |
| Spironolactone | 15 | $75 | $5 |
| Clonidine | 16 | $74 | $5 |
| Mupirocin | 15 | $68 | $5 |
| Prednisone | 14 | $67 | $5 |
| Fluoxetine | 22 | $56 | $3 |
| Donepezil | 12 | $56 | $5 |
| Alprazolam | 15 | $50 | $3 |
| Cephalexin | 16 | $36 | $2 |
Year by year
| 2024 | 3,866 | 490 | 2% (86) | 15% | $617,271 |
| 2023 | 3,690 | 477 | 3% (117) | 14% | $581,459 |
| 2022 | 3,395 | 455 | 4% (148) | 15% | $499,113 |
| 2021 | 3,453 | 458 | 6% (196) | 15% | $405,086 |
| 2020 | 2,435 | 348 | 8% (185) | None | $251,787 |
| 2019 | 330 | 109 | 10% (32) | None | $24,249 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 79 drugs
| Eliquis | 53 | $78,812 | $1,487 |
| Jardiance | 48 | $60,425 | $1,259 |
| Trulicity | 31 | $59,662 | $1,925 |
| Creon | 20 | $56,161 | $2,808 |
| Ozempic | 25 | $35,995 | $1,440 |
| Xarelto | 12 | $11,287 | $941 |
| Symbicort | 17 | $10,524 | $619 |
| Atorvastatin | 346 | $6,060 | $18 |
| Dronabinol | 11 | $5,521 | $502 |
| Losartan | 206 | $3,942 | $19 |
| Wixela Inhub | 11 | $3,659 | $333 |
| Rosuvastatin | 87 | $3,581 | $41 |
| Tamsulosin | 103 | $2,372 | $23 |
| Amlodipine Besylate | 157 | $2,259 | $14 |
| Duloxetine | 33 | $2,121 | $64 |
| Levothyroxine | 114 | $2,005 | $18 |
| Metoprolol | 75 | $1,820 | $24 |
| Metformin | 117 | $1,766 | $15 |
| Pregabalin | 23 | $1,764 | $77 |
| Hydrocodone-Acetaminophen | 58 | $1,719 | $30 |
| Valsartan | 31 | $1,483 | $48 |
| Omeprazole | 61 | $1,427 | $23 |
| Gabapentin | 35 | $1,414 | $40 |
| Pantoprazole | 53 | $1,407 | $27 |
| Synthroid | 11 | $1,383 | $126 |
| Albuterol Sulfate Hfa | 39 | $1,296 | $33 |
| Colchicine | 12 | $1,247 | $104 |
| Lisinopril | 81 | $1,031 | $13 |
| Allopurinol | 52 | $799 | $15 |
| Bupropion Xl | 13 | $765 | $59 |
| Potassium Chloride | 12 | $761 | $63 |
| Ventolin Hfa | 12 | $739 | $62 |
| Losartan-Hydrochlorothiazide | 22 | $734 | $33 |
| Clonidine | 12 | $676 | $56 |
| Simvastatin | 51 | $669 | $13 |
| Ezetimibe | 12 | $560 | $47 |
| Famotidine | 12 | $530 | $44 |
| Zolpidem | 29 | $528 | $18 |
| Carvedilol | 33 | $524 | $16 |
| Fluticasone Propionate | 28 | $517 | $18 |
| Metformin Hcl Er | 39 | $472 | $12 |
| Oxycodone-Acetaminophen | 12 | $472 | $39 |
| Trazodone | 44 | $459 | $10 |
| Terazosin | 20 | $435 | $22 |
| Finasteride | 21 | $398 | $19 |
| Paxlovid (Eua) | 40 | $375 | $9 |
| Ketoconazole | 22 | $352 | $16 |
| Alendronate | 28 | $351 | $13 |
| Cyclobenzaprine | 30 | $342 | $11 |
| Pravastatin | 19 | $323 | $17 |
| Nifedipine Er | 11 | $314 | $29 |
| Triamterene-Hydrochlorothiazid | 20 | $291 | $15 |
| Clopidogrel | 24 | $272 | $11 |
| Metoprolol | 30 | $268 | $9 |
| Furosemide | 30 | $265 | $9 |
| Lovastatin | 12 | $252 | $21 |
| Atenolol | 21 | $246 | $12 |
| Benazepril | 14 | $225 | $16 |
| Sertraline | 14 | $225 | $16 |
| Chlorthalidone | 12 | $217 | $18 |
| Hydrochlorothiazide | 43 | $216 | $5 |
| Prednisone | 16 | $216 | $14 |
| Ibuprofen | 16 | $211 | $13 |
| Triamcinolone Acetonide | 33 | $208 | $6 |
| Oxycodone | 26 | $199 | $8 |
| Spironolactone | 13 | $195 | $15 |
| Montelukast | 12 | $175 | $15 |
| Mupirocin | 12 | $136 | $11 |
| Ciprofloxacin | 11 | $135 | $12 |
| Amoxicillin-Clavulanate Potass | 21 | $132 | $6 |
| Hydromorphone | 11 | $127 | $12 |
| Lorazepam | 17 | $110 | $6 |
| Azithromycin | 16 | $107 | $7 |
| Citalopram Hbr | 12 | $106 | $9 |
| Glipizide | 13 | $105 | $8 |
| Cephalexin | 11 | $88 | $8 |
| Alprazolam | 20 | $88 | $4 |
| Sildenafil Citrate | 12 | $51 | $4 |
| Baclofen | 11 | $50 | $5 |
2022: 74 drugs
| Trulicity | 64 | $86,076 | $1,345 |
| Eliquis | 50 | $62,994 | $1,260 |
| Jardiance | 50 | $56,799 | $1,136 |
| Creon | 12 | $30,862 | $2,572 |
| Januvia | 11 | $17,252 | $1,568 |
| Brilinta | 19 | $12,384 | $652 |
| Myrbetriq | 17 | $11,560 | $680 |
| Atorvastatin | 351 | $4,889 | $14 |
| Rosuvastatin | 77 | $4,332 | $56 |
| Levothyroxine | 98 | $2,179 | $22 |
| Duloxetine | 28 | $1,987 | $71 |
| Omeprazole | 84 | $1,763 | $21 |
| Pregabalin | 24 | $1,741 | $73 |
| Losartan | 145 | $1,729 | $12 |
| Hydrocodone-Acetaminophen | 63 | $1,664 | $26 |
| Metoprolol | 72 | $1,580 | $22 |
| Amlodipine Besylate | 176 | $1,545 | $9 |
| Albuterol Sulfate Hfa | 33 | $1,441 | $44 |
| Testosterone | 11 | $1,440 | $131 |
| Metformin | 110 | $1,434 | $13 |
| Gabapentin | 41 | $1,340 | $33 |
| Tamsulosin | 75 | $1,318 | $18 |
| Lisinopril | 93 | $1,313 | $14 |
| Trazodone | 47 | $1,201 | $26 |
| Pantoprazole | 48 | $1,040 | $22 |
| Oxycodone-Acetaminophen | 21 | $976 | $46 |
| Bupropion Xl | 15 | $864 | $58 |
| Losartan-Hydrochlorothiazide | 22 | $618 | $28 |
| Valsartan | 12 | $609 | $51 |
| Pyridostigmine | 13 | $556 | $43 |
| Chlorthalidone | 11 | $553 | $50 |
| Ketoconazole | 23 | $548 | $24 |
| Sertraline | 28 | $536 | $19 |
| Carvedilol | 23 | $510 | $22 |
| Buspirone | 13 | $474 | $36 |
| Labetalol | 12 | $437 | $36 |
| Zolpidem | 21 | $410 | $20 |
| Metformin Hcl Er | 36 | $404 | $11 |
| Furosemide | 29 | $390 | $13 |
| Terazosin | 13 | $375 | $29 |
| Allopurinol | 27 | $342 | $13 |
| Cyclobenzaprine | 26 | $332 | $13 |
| Lisinopril-Hydrochlorothiazide | 14 | $317 | $23 |
| Montelukast | 19 | $309 | $16 |
| Lovastatin | 17 | $302 | $18 |
| Atenolol | 20 | $282 | $14 |
| Clopidogrel | 18 | $276 | $15 |
| Fluticasone Propionate | 20 | $270 | $13 |
| Baclofen | 11 | $269 | $24 |
| Metoprolol | 20 | $267 | $13 |
| Hydrochlorothiazide | 50 | $255 | $5 |
| Oxycodone | 29 | $253 | $9 |
| Triamterene-Hydrochlorothiazid | 21 | $242 | $12 |
| Alendronate | 20 | $234 | $12 |
| Hydrocortisone | 11 | $222 | $20 |
| Latanoprost | 12 | $210 | $18 |
| Benazepril | 14 | $209 | $15 |
| Clonidine | 14 | $206 | $15 |
| Diclofenac | 12 | $200 | $17 |
| Hydromorphone | 14 | $188 | $13 |
| Finasteride | 11 | $181 | $16 |
| Triamcinolone Acetonide | 21 | $176 | $8 |
| Pravastatin | 11 | $167 | $15 |
| Ibuprofen | 11 | $143 | $13 |
| Glipizide | 17 | $138 | $8 |
| Lorazepam | 18 | $137 | $8 |
| Hydroxyzine | 16 | $136 | $9 |
| Simvastatin | 23 | $119 | $5 |
| Venlafaxine Hcl Er | 11 | $112 | $10 |
| Oxybutynin Chloride | 11 | $100 | $9 |
| Prednisone | 13 | $100 | $8 |
| Mupirocin | 13 | $78 | $6 |
| Alprazolam | 25 | $52 | $2 |
| Sildenafil Citrate | 13 | $48 | $4 |
2021: 74 drugs
| Trulicity | 64 | $57,032 | $891 |
| Jardiance | 44 | $42,418 | $964 |
| Eliquis | 32 | $39,481 | $1,234 |
| Creon | 15 | $31,271 | $2,085 |
| Symbicort | 26 | $14,100 | $542 |
| Lantus Solostar | 16 | $9,464 | $591 |
| Incruse Ellipta | 13 | $6,365 | $490 |
| Atorvastatin | 285 | $4,781 | $17 |
| Testosterone | 14 | $3,062 | $219 |
| Pregabalin | 32 | $2,528 | $79 |
| Levothyroxine | 108 | $2,429 | $22 |
| Esomeprazole Magnesium | 11 | $2,310 | $210 |
| Amlodipine Besylate | 184 | $2,109 | $11 |
| Hydrocodone-Acetaminophen | 75 | $1,822 | $24 |
| Valsartan | 17 | $1,814 | $107 |
| Rosuvastatin | 54 | $1,689 | $31 |
| Tamsulosin | 88 | $1,663 | $19 |
| Losartan | 96 | $1,579 | $16 |
| Duloxetine | 33 | $1,480 | $45 |
| Albuterol Sulfate Hfa | 36 | $1,444 | $40 |
| Metformin | 124 | $1,401 | $11 |
| Omeprazole | 65 | $1,388 | $21 |
| Lisinopril | 109 | $1,226 | $11 |
| Gabapentin | 48 | $1,218 | $25 |
| Trazodone | 45 | $1,196 | $27 |
| Cyclobenzaprine | 38 | $1,057 | $28 |
| Celecoxib | 13 | $998 | $77 |
| Oxycodone-Acetaminophen | 31 | $917 | $30 |
| Metoprolol | 45 | $855 | $19 |
| Labetalol | 21 | $815 | $39 |
| Pantoprazole | 37 | $808 | $22 |
| Chlorthalidone | 15 | $761 | $51 |
| Losartan-Hydrochlorothiazide | 19 | $727 | $38 |
| Diclofenac | 22 | $717 | $33 |
| Ventolin Hfa | 11 | $638 | $58 |
| Metformin Hcl Er | 37 | $626 | $17 |
| Oxycodone | 35 | $547 | $16 |
| Sertraline | 26 | $527 | $20 |
| Carvedilol | 30 | $524 | $17 |
| Diltiazem 24hr Er (Cd) | 11 | $502 | $46 |
| Baclofen | 11 | $499 | $45 |
| Zolpidem | 32 | $477 | $15 |
| Buspirone | 11 | $450 | $41 |
| Lovastatin | 30 | $429 | $14 |
| Ketoconazole | 20 | $420 | $21 |
| Hydromorphone | 11 | $411 | $37 |
| Alendronate | 42 | $388 | $9 |
| Metoprolol | 25 | $357 | $14 |
| Citalopram Hbr | 33 | $336 | $10 |
| Furosemide | 40 | $333 | $8 |
| Atenolol | 26 | $331 | $13 |
| Mirtazapine | 14 | $329 | $24 |
| Simvastatin | 31 | $317 | $10 |
| Benazepril | 14 | $290 | $21 |
| Tramadol | 22 | $258 | $12 |
| Famotidine | 15 | $243 | $16 |
| Lisinopril-Hydrochlorothiazide | 17 | $232 | $14 |
| Pravastatin | 11 | $225 | $20 |
| Montelukast | 13 | $222 | $17 |
| Triamterene-Hydrochlorothiazid | 19 | $218 | $11 |
| Clopidogrel | 15 | $216 | $14 |
| Hydrochlorothiazide | 61 | $209 | $3 |
| Finasteride | 12 | $205 | $17 |
| Olmesartan Medoxomil | 13 | $171 | $13 |
| Fluticasone Propionate | 19 | $148 | $8 |
| Triamcinolone Acetonide | 27 | $126 | $5 |
| Sumatriptan | 17 | $117 | $7 |
| Lorazepam | 18 | $115 | $6 |
| Ibuprofen | 14 | $99 | $7 |
| Prednisone | 23 | $98 | $4 |
| Glipizide | 12 | $96 | $8 |
| Alprazolam | 17 | $93 | $5 |
| Amoxicillin-Clavulanate Potass | 12 | $85 | $7 |
| Clonazepam | 11 | $84 | $8 |
2020: 55 drugs
| Jardiance | 42 | $33,630 | $801 |
| Eliquis | 17 | $22,222 | $1,307 |
| Trulicity | 23 | $21,533 | $936 |
| Creon | 11 | $19,455 | $1,769 |
| Symbicort | 23 | $11,108 | $483 |
| Tradjenta | 12 | $9,913 | $826 |
| Atorvastatin | 161 | $2,494 | $15 |
| Pregabalin | 27 | $2,191 | $81 |
| Levothyroxine | 65 | $1,620 | $25 |
| Amlodipine Besylate | 111 | $1,300 | $12 |
| Hydrocodone-Acetaminophen | 58 | $1,239 | $21 |
| Albuterol Sulfate Hfa | 30 | $1,234 | $41 |
| Oxycodone-Acetaminophen | 32 | $1,125 | $35 |
| Gabapentin | 45 | $1,089 | $24 |
| Duloxetine | 23 | $1,047 | $46 |
| Losartan | 48 | $1,006 | $21 |
| Ventolin Hfa | 15 | $981 | $65 |
| Diclofenac | 33 | $921 | $28 |
| Rosuvastatin | 26 | $845 | $33 |
| Ketoconazole | 31 | $818 | $26 |
| Hydromorphone | 22 | $755 | $34 |
| Metoprolol | 27 | $716 | $27 |
| Metformin | 74 | $685 | $9 |
| Tamsulosin | 40 | $676 | $17 |
| Mirtazapine | 21 | $660 | $31 |
| Omeprazole | 38 | $652 | $17 |
| Lisinopril | 69 | $576 | $8 |
| Trazodone | 39 | $521 | $13 |
| Chlorthalidone | 15 | $512 | $34 |
| Losartan-Hydrochlorothiazide | 12 | $439 | $37 |
| Pantoprazole | 32 | $434 | $14 |
| Zolpidem | 30 | $411 | $14 |
| Labetalol | 12 | $347 | $29 |
| Oxycodone | 30 | $329 | $11 |
| Cyclobenzaprine | 17 | $286 | $17 |
| Metformin Hcl Er | 31 | $277 | $9 |
| Sertraline | 20 | $270 | $14 |
| Hydrochlorothiazide | 48 | $247 | $5 |
| Citalopram Hbr | 22 | $232 | $11 |
| Triamterene-Hydrochlorothiazid | 15 | $227 | $15 |
| Atenolol | 18 | $218 | $12 |
| Benazepril | 15 | $213 | $14 |
| Furosemide | 28 | $205 | $7 |
| Pravastatin | 13 | $203 | $16 |
| Simvastatin | 33 | $203 | $6 |
| Fluticasone Propionate | 16 | $196 | $12 |
| Spironolactone | 12 | $189 | $16 |
| Triamcinolone Acetonide | 39 | $188 | $5 |
| Metoprolol | 22 | $181 | $8 |
| Ondansetron Odt | 13 | $169 | $13 |
| Carvedilol | 19 | $162 | $9 |
| Clonazepam | 13 | $135 | $10 |
| Lorazepam | 14 | $130 | $9 |
| Clopidogrel | 11 | $121 | $11 |
| Alendronate | 24 | $114 | $5 |
2019: 3 drugs
| Atorvastatin | 18 | $332 | $18 |
| Amlodipine Besylate | 33 | $241 | $7 |
| Hydrochlorothiazide | 11 | $47 | $4 |
Money from drug and device companies
$22 in 2024
| 2024 | 1 | 1 | None | $22 |
| 2022 | 1 | 1 | None | $15 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Bolton Medical | Relay Thoracic Stent-Graft With Plus Delivery System | $22 | 1 payment
|
See the published payment
| Bolton Medical | Meals · 2024-05-07 | Relay Thoracic Stent-Graft With Plus Delivery System | $22 |
See earlier years (2022)
2022: $15
| E.R. Squibb & Sons L.L.C. | Opdivo | $15 | 1 payment
|
Professional record
- NPI
- 1740643600
- Licence
- CA A152565California A152565: Current · expires 2027-11-30
- Trained
- New York University School of Medicine, 2016
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2016-03-29
- NPI last updated
- 2024-04-18
- NPI record certified
- 2024-04-18
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305